ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
69,430.01
0.14%
S&P 500
5,346.99
-0.11%
Dow Jones
38,798.99
-0.22%
US Dollar vs Yen
156.7275
0.02%
Brent Oil
79.395
0.00%
Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Omrix Biopharmaceuticals (MM) (OMRI)

  7. Omrix Biopharmaceuticals (MM) (OMRI) ニュース

OMRI

Omrix Biopharmaceuticals (MM) (OMRI)

Omrix Biopharmaceuticals (MM)
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:OMRI
日付受信時刻ニュースソース見出しコード企業名
2008/12/3107 : 21Edgar (US Regulatory)(25-NSE)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
2008/12/3106 : 59Edgar (US Regulatory)Notice of Termination of a Foreign Private Issuer's Registration of a Class of Securities under Section 12(g) (15F-12G)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
2008/12/3105 : 34Edgar (US Regulatory)Amended Statement of Beneficial Ownership (SC 13D/A)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
2008/12/2923 : 57MarketwiredBridgewaterEquity.com Free Fundamental Sector & Market Research on BEBE, OMRI, SONS and CALMNASDAQ:OMRIOmrix Biopharmaceuticals (MM)
2008/12/2920 : 27Edgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
2008/12/2800 : 08PR Newswire (US)Johnson & Johnson Completes Tender Offer for Omrix Biopharmaceuticals, Inc.NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
2008/12/2007 : 42PR Newswire (US)Johnson & Johnson Extends Tender Offer for Omrix Biopharmaceuticals, Inc.NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
2008/12/2007 : 00Edgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
2008/12/2006 : 49Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
2008/12/1920 : 02Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
2008/12/1906 : 02Edgar (US Regulatory)Statement of Beneficial Ownership (SC 13D)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
2008/12/1807 : 24Edgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
2008/12/1807 : 03Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
2008/12/1720 : 04Edgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
2008/12/1305 : 38Edgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
2008/12/1207 : 40PR Newswire (US)Johnson & Johnson Announces Receipt of Israeli Antitrust Approval for Acquisition of OmrixNASDAQ:OMRIOmrix Biopharmaceuticals (MM)
2008/12/0606 : 52Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
2008/12/0403 : 45MarketwiredLaw Offices of Brian M. Felgoise, P.C. Announces Class Action Lawsuit on Behalf of Shareholders of Omrix Biopharmaceuticals, IncNASDAQ:OMRIOmrix Biopharmaceuticals (MM)
2008/12/0207 : 30Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
2008/12/0207 : 25Edgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
2008/11/2620 : 01Edgar (US Regulatory)Statement of Ownership: Solicitation (SC 14D9)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
2008/11/2607 : 12Edgar (US Regulatory)Current report filing (8-K)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
2008/11/2603 : 10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
2008/11/2602 : 43Edgar (US Regulatory)Written communication by the subject company relating to a third party tender offer (SC14D9C)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
2008/11/2602 : 38PR Newswire (US)Johnson & Johnson Begins Tender Offer to Acquire OmrixNASDAQ:OMRIOmrix Biopharmaceuticals (MM)
2008/11/2507 : 06Edgar (US Regulatory)Written communication relating to an issuer or third party (SC TO-C)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
2008/11/2420 : 30PR Newswire (US)Johnson & Johnson Announces Definitive Agreement to Acquire OmrixNASDAQ:OMRI
2008/11/2201 : 03Edgar (US Regulatory)Current report filing (8-K)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
2008/11/1101 : 25Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
2008/11/0703 : 47Business WireOmrix Biopharmaceuticals to Webcast Presentation at Credit Suisse Annual Healthcare ConferenceNASDAQ:OMRIOmrix Biopharmaceuticals (MM)
 Showing the most relevant articles for your search:NASDAQ:OMRI

最近閲覧した銘柄

NYSE
CVX
Chevron
NYSE
XOM
Exxon Mobil
FX
USDGBP
US Dollar vs Sterling
COIN
BTCUSD
Bitcoin
USI
USTECH100
US Tech 100
NYSE
AXP
American Express
NYSE
KO
Coca Cola
SPI
SP500
S&P 500
CCOM
US500
US 500
NASDAQ
MSFT
Microsoft
CCOM
SILVER
SILVER
COIN
ETHUSD
Ethereum
NASDAQ
QQQ
Invesco QQQ Trust Series 1
USOTC
BASFY
BASF (QX)
COIN
SOLUSD
Solana
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有